Loteprednol etabonate for inflammatory conditions of the anterior segment of the eye: twenty years of clinical experience with a retrometabolically designed corticosteroid Review

sustainable development goals

publication date

  • January 1, 2018

webpage

published in

keywords

  • Anterior segment
  • cataract
  • conjunctivitis
  • dry eye
  • intraocular pressure
  • loteprednol etabonate
  • ocular surface disease
  • post-operative ocular inflammation
  • retrometabolic drug design
  • uveitis

start page

  • 337

end page

  • 353

volume

  • 19

issue

  • 4